Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | PRKCA | P17252 | 2/20 | 0.39 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA7 | P43166 | 4/20 | 0.38 |
| ▸ | CA9 | Q16790 | 4/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2128862 | 0.87 | ALDH1A1 (0.49) | ALDH1A1TSHRMAPK1PRKCAPRKCD | |
| SCHEMBL4885782 | 0.87 | ALDH1A1 (0.43) | ALDH1A1TSHRMAPK1KDM4EKMT2A | |
| SCHEMBL128505 | 0.85 | CA12 (0.46) | ALDH1A1TSHRMAPK1PRKCAPRKCD | |
| SCHEMBL3074456 | 0.82 | PRKCA (0.45) | ALDH1A1PRKCAPRKCDTAS1R3TAS1R1 | |
| SCHEMBL1513875 | 0.82 | ALDH1A1 (0.52) | ALDH1A1TSHRMAPK1CA2KDM4E | |
| SCHEMBL2061233 | 0.79 | MAPT (0.49) | ALDH1A1TSHRMAPK1CA12CA1 | |
| Terephthalic Acid SCHEMBL8439001 | 0.79 | MAPT (0.49) | ALDH1A1TSHRMAPK1CA12CA1 | |
| SCHEMBL13218959 | 0.79 | SLC6A2 (0.51) | ALDH1A1TSHRCA12CA1CA2 | |
| SCHEMBL435764 | 0.78 | ALDH1A1 (0.53) | ALDH1A1TSHRMAPK1PRKCAPRKCD | |
| SCHEMBL29808730 | 0.78 | ALDH1A1 (0.53) | ALDH1A1TSHRMAPK1PRKCAPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220211725-A1 | Pharmaceutical Composition Comprising Venetoclax | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2022-07-07 | — | — | US | claimed |
| WO-2020225738-A1 | PHARMACEUTICAL COMPOSITION COMPRISING VENETOCLAX | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2020-11-12 | — | — | WO | claimed |
| EP-1847257-B1 | Solid preparation comprising enteric solid dispersion | SHINETSU CHEMICAL CO (JP) | 2017-11-22 | — | — | EP | claimed |
| US-20140370091-A1 | Method for Producing Aqueous Enteric Coating Liquid, Solid Preparation, and Method for Producing Same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-18 | — | — | US | claimed |
| EP-2813218-A1 | Method for producing aqueous enteric coating liquid, solid preparation, and method for producing same | Shin-Etsu Chemical Co., Ltd. (JP) | 2014-12-17 | — | — | EP | claimed |
| US-20080038340-A1 | Solid dosage form of enteric solid dispersion and method for producing the same | SHIN-ETSU CHEMICAL CO., LTD. | 2008-02-14 | — | — | US | claimed |
| EP-1886673-A2 | Solid dosage form of enteric solid dispersion and method for producing the same | Shin-Etsu Chemical Co., Ltd. (JP) | 2008-02-13 | — | — | EP | claimed |
| US-20070248682-A1 | SOLID PREPARATION COMPRISING ENTERIC SOLID DISPERSION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-10-25 | — | — | US | claimed |
| EP-1847257-A2 | Solid preparation comprising enteric solid dispersion | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-10-24 | — | — | EP | claimed |
| US-20250242031-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | PURDUE RESEARCH FOUNDATION | 2025-07-31 | — | — | US | disclosed |
| EP-4479092-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | Purdue Research Foundation (US) | 2024-12-25 | — | — | EP | disclosed |
| WO-2023154171-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | PURDUE RESEARCH FOUNDATION (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20220211725-A1 | Pharmaceutical Composition Comprising Venetoclax | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2022-07-07 | — | — | US | disclosed |
| US-11292793-B2 | Solid dispersions of amorphous Lumateperone p-Tosylate | DR. REDDY'S LABORATORIES LIMITED (IN) | 2022-04-05 | — | — | US | disclosed |
| US-20080038340-A1 | Solid dosage form of enteric solid dispersion and method for producing the same | SHIN-ETSU CHEMICAL CO., LTD. | 2008-02-14 | — | — | US | disclosed |
| EP-1886673-A2 | Solid dosage form of enteric solid dispersion and method for producing the same | Shin-Etsu Chemical Co., Ltd. (JP) | 2008-02-13 | — | — | EP | disclosed |
| US-20070248682-A1 | SOLID PREPARATION COMPRISING ENTERIC SOLID DISPERSION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-10-25 | — | — | US | disclosed |
| EP-1847257-A2 | Solid preparation comprising enteric solid dispersion | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-10-24 | — | — | EP | disclosed |
| US-20070196399-A1 | ENTERIC-COATED PREPARATION COVERED WITH ENTERIC COATING MATERIAL FOR SITE-SPECIFIC DELIVERY OF DRUG TO SITE WITHIN THE SMALL INTESTINE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| EP-1820498-A2 | Enteric-coated preparation for site-specific delivery of drug to site within the small intestine | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11292793-B2 | Solid dispersions of amorphous Lumateperone p-Tosylate | HTR2A, HTR2C, HTR1A | ALDH1A1 2652/4885TSHR 100/4885MAPK1 4061/4885 |
| US-20250242031-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | SRI, SYNGR2, PSD | ALDH1A1 3898/4885TSHR 4586/4885MAPK1 1802/4885 |
| US-20220211725-A1 | Pharmaceutical Composition Comprising Venetoclax | U2AF1, SF3B1, SF3B3 | ALDH1A1 3436/4885TSHR 4796/4885MAPK1 3091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.